ClinicalTrials.gg
BiologicalDrug

Margetuximab clinical trials

Also written MGAH22 and Margenza.

studies test it
9
open now
0
in phase 3
2
first study started
2010

How each study uses margetuximab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
16 Dec 2020 · MARGENZA · BLA 761150 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Margetuximab
8

Brand

Margenza
4

Development codes

MGAH22
6

Studies by the year they started

9 studies that test it; most in 2020 (2)

Studies that test margetuximab, by start year
YearStudies
20101
20131
20151
20161
20171
20191
20202
20221

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
6
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 2

MacroGenics (6) · Dana-Farber Cancer Institute (1) · Zai Lab (Shanghai) Co., Ltd. (1) · MedSIR (1)

Often tested with

Tested in the same studies.

Tebotelimab (2) · Retifanlimab (1) · Capecitabine (1)

Studies

Open first, then newest update. How each study uses margetuximab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 9

Codes

What other systems call margetuximab · ClinicalTrials.gg INT000659

  • MeSH (NLM) C000617981margetuximabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) K911R84KEWMARGETUXIMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2473851One source FDA
  • Wikidata Q109356831MargetuximabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C91733MargetuximabOne source FDA
  • DrugBank DB14967One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.